BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/12/2026 10:01:53 AM | Browse: 7 | Download: 3
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Basic Study |
| Article Title |
CaMKK2 modulates macrophage polarization and is associated with immunometabolic transcriptional changes under high glucose conditions
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ping Tang, Wei-Chang Guo, He-Jia Yin and Hui-Fang Li |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82160165 |
| the Famous Doctor Special Program of the Yunnan Xingdian Talent Support Plan |
RLMY20220009 |
| the Young and Middle-Aged Academic and Technical Leaders Reserve Talent Project of Yunnan Province |
202105AC160093 |
|
| Corresponding Author |
Hui-Fang Li, Diabetes, First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming 650032, Yunnan Province, China. lihf@ydyy.cn |
| Key Words |
Calcium/calmodulin-dependent protein kinase kinase 2; Macrophage polarization; Type 2 diabetes mellitus; Transcriptomics; AKT signaling; High glucose |
| Core Tip |
Under high glucose (HG) conditions, gain- and loss-of-function experiments targeting calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) revealed changes in macrophage polarization-associated markers. Bulk RNA sequencing identified inflammatory and metabolic transcriptional differences between CAMKK2-overexpressing and untransduced cells. CAMKK2 overexpression reduced protein kinase B (AKT) phosphorylation, whereas CAMKK2 knockdown increased it, and the AKT activator SC79 partially attenuated CaMKK2-associated CD86 expression. These findings suggest that CaMKK2 modulates macrophage inflammatory responses under HG conditions, with AKT signaling potentially contributing to the observed effects. |
| Citation |
Tang P, Guo WC, Yin HJ, Li HF. CaMKK2 modulates macrophage polarization and is associated with immunometabolic transcriptional changes under high glucose conditions. World J Diabetes 2026; In press
|
| PDF |
126373-in-press.pdf
|
 |
Received |
|
2026-08-03 08:32 |
 |
Peer-Review Started |
|
2026-08-05 05:42 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2026-09-01 05:56 |
 |
Revised |
|
2026-09-14 10:23 |
 |
Publication Fee Transferred |
|
2026-10-15 15:10 |
 |
Second Decision by Editor |
|
2026-11-06 03:20 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-11-12 10:01 |
 |
Articles in Press |
|
2026-11-12 10:01 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.